Showing 8601-8610 of 21414 results for "".
Difficulty with Diabetes: Strategies to Overcome Challenging Cases
https://reachmd.com/programs/diabetes-discourse/difficulty-with-diabetes-strategies-to-overcome-challenging-cases/12060/What are some strategies endocrinologists can use to better manage challenging cases?How Will Pharmacogenomics Play a Role in Diabetes Therapy?
https://reachmd.com/programs/diabetes-discourse/how-will-pharmacogenomics-play-a-role-in-diabetes-therapy/4879/Pharmacogenomics is applied to select medications with the goal of optimizing drug therapy: maximizing efficacy, minimizing toxicity, and minimizing pharmacokinetic and pharmacodynamic variability. Join guest host, Dr. Candis Morello and Dr. Joseph Ma, assistant professor of clinical pharmacy at theThe Need to Preserve Beta Cell Function Early
https://reachmd.com/programs/diabetes-discourse/the-need-to-preserve-beta-cell-function-early/5858/New information on the state of impaired glucose tolerance indicates that the level of beta cell loss is greater than once considered. New treatment regimens are being considered to combat both the insulin sensitivity and beta cell loss for type 2 diabetes. What do health care professionals need toAddressing the Challenges of Influenza Vaccination on US College Campuses
https://reachmd.com/programs/everyday-family-medicine/addressing-the-challenges-of-influenza-vaccination-on-us-college-campuses/10005/Dr. Lisa Ipp explains why college students aren't getting flu shots and what health care officials can do to reverse this trend.Glycemic Control and Macrovascular Outcomes in Patients with Diabetes Using the Archimedes Model
https://reachmd.com/programs/diabetes-discourse/glycemic-control-and-macrovascular-outcomes-in-patients-with-diabetes-using-the-archimedes-model/5906/The assessment of intensive glycemic control in preventing cardiovascular disease is unclear. Discrepancies in recent clinical trials such as ACCORD, ADVANCE, PROactive and UKPDS 80 may reflect difference in study design and patients, versus glycemic control. How can using the Archimedes model illumInterstitial Pneumonia with Autoimmune Features (IPAF): A Research Classification
https://reachmd.com/programs/cme/interstitial-pneumonia-with-autoimmune-features-ipaf-a-research-classification/10943/Just what exactly is IPAF, and how can I help my patients?A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
https://reachmd.com/programs/cme/a-case-of-missed-diagnosis-part-of-the-focused-sight-initiative-quality-improvement-interventions-in-retinal-disease/37713/Examine a case of misdiagnosed proliferative diabetic retinopathy, highlighting risk factors, imaging findings, and referral timing.Keeping an Eye on Macular Degeneration
https://reachmd.com/programs/revealing-retina/keeping-an-eye-on-macular-degeneration/2158/Dr. Roy Levit welcomes Dr. Julia Haller to The Revealing Retina. Dr. Haller is President of the American Society of Retina Specialists and Chairman, Wills Eye Hospital, Philadelphia. They will discuss the different types of macular degeneration, the demographics involved and who should be treating iHow Your Words Will (or Won't) Instill Confidence in Your Patients
https://reachmd.com/programs/speaking-of/how-your-words-will-or-wont-instill-confidence-your-patients/7925/Imagine if you are a patient about to receive some difficult news. The doctor walks in and says "I think this is a temporary setback” or "I believe you’ll be okay.” How would you react to news presented in this way, and would you have confidence in your doctor's ability to see you through the healthThe Role of PARP Inhibitors in Metastatic Breast Cancer
https://reachmd.com/programs/project-oncology/the-role-of-parp-inhibitors-in-metastatic-breast-cancer/15820/PARP inhibitors are a type of targeted therapy used in the treatment of MBC by blocking the activity of an enzyme. Read more.